Your browser does not support javascript:   Search for gard hereSearch for news-and-events here.


Genetic and Rare Diseases Information Center (GARD)

Print friendly version

Kikuchi disease

Other Names for this Disease
  • Histiocytic necrotising lymphadenitis
  • Kikuchi necrotizing lymphadenitis
  • Kikuchi's disease
  • Kikuchi-Fujimoto's disease
  • Nosocomial Kikuchi's disease
See Disclaimer regarding information on this site. Some links on this page may take you to organizations outside of the National Institutes of Health.


Newline Maker

How might Kikuchi disease be treated?

Kikuchi disease is typically self-limited, resolving on its own within one to four months. However, treatment may relieve some of the signs and symptoms of the condition. Analgesics-antipyretics (drugs that relieve pain and fever) and nonsteroidal anti-inflammatory drugs (NSAIDs) may be used to alleviate lymph node tenderness and fever. The use of corticosteroids has been recommended in severe extranodal or generalized Kikuchi disease. Affected individuals should be followed for several years to rule out the development of systemic lupus erythematosus (SLE).[1]

Additional information on the treatment of Kikuchi disease is available on Medscape Reference's Web site and can be viewed by clicking here.
Last updated: 12/12/2012

  1. Xavier Bosch and Antonio Guilabert. Kikuchi-Fujimoto disease. OJRD. 2006; 1:18: Accessed 12/12/2012.

Clinical Trials & Research for this Disease

  • lists trials that are studying or have studied Kikuchi disease. Click on the link to go to to read descriptions of these studies.